To better understand the relevance and underlying mechanisms of HSPB1 expression in breast cancer, we summarized the distribution of clinicopathological information of patients in HSPB1 high expression group and HSPB1 low expression group (Table 1). This evidence concerns the gene HSPB1 and breast carcinoma.